Compounds > tiletamine hydrochloride
Page last updated: 2024-08-22

tiletamine hydrochloride and Cirrhosis

tiletamine hydrochloride has been researched along with Cirrhosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Dacso, CC; Gaber, MW; Kim, JH; Leach, JP; Lonard, DM; Martin, JF; Monroe, TO; Mullany, LK; O'Malley, BW; Ortiz, AR; Rohira, AD; Rosengart, TK; Sarkar, P; Sikora, AG; Song, Y; Stork, B; York, B1
Kojima, I; Sidthipong, K; Takei, I; Todo, S; Umezawa, K1
Cai, L; Liang, G; Liu, Q; McClung, K; Pan, Y; Sun, J; Sun, W; Tan, Y; Wang, Y; Zhao, Y; Zhou, S1
Cai, L; Cai, Y; Feng, Z; Hu, J; Li, J; Li, X; Liang, G; Pan, Y; Wang, Y; Yang, S; Yu, C1
Asano, T; Hayakawa, M; Kosaka, T; Miyajima, A; Seta, K; Umezawa, K1

Reviews

1 review(s) available for tiletamine hydrochloride and Cirrhosis

ArticleYear
Screening of new bioactive metabolites for diabetes therapy.
    Internal and emergency medicine, 2013, Volume: 8 Suppl 1

    Topics: Animals; Benzamides; Cell Differentiation; Cyclohexanones; Diabetes Mellitus, Type 1; Fibrosis; Humans; Insulin-Secreting Cells; Islets of Langerhans Transplantation; NF-kappa B; Vinca Alkaloids

2013

Other Studies

4 other study(ies) available for tiletamine hydrochloride and Cirrhosis

ArticleYear
A steroid receptor coactivator stimulator (MCB-613) attenuates adverse remodeling after myocardial infarction.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Cell Differentiation; Cyclohexanones; Fibroblasts; Fibrosis; Heart Function Tests; Inflammation; Macrophages; Mice; Myocardial Infarction; Pyridines; RAW 264.7 Cells; Receptors, Steroid; RNA; Transcription, Genetic; Ventricular Remodeling

2020
Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression.
    American journal of physiology. Endocrinology and metabolism, 2014, Jun-01, Volume: 306, Issue:11

    Topics: Animals; Apoptosis; Benzylidene Compounds; Blood Pressure; Blotting, Western; Coloring Agents; Curcumin; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Echocardiography; Endoplasmic Reticulum Stress; Fibrosis; Heart; JNK Mitogen-Activated Protein Kinases; Lipid Peroxidation; Male; Metallothionein; Mice; Mice, Inbred C57BL; Myocardium; Oxidative Stress; Phosphorylation; Protein Kinase Inhibitors; Real-Time Polymerase Chain Reaction

2014
Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats.
    British journal of pharmacology, 2012, Volume: 166, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylidene Compounds; Blood Glucose; Blotting, Western; Body Weight; Cell Culture Techniques; Cell Movement; Curcumin; Cyclohexanones; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Fibrosis; Glucose; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Organ Size; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction

2012
Novel nuclear factor kappa B activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction.
    The Journal of urology, 2003, Volume: 169, Issue:4

    Topics: Animals; Apoptosis; Benzamides; Cell Division; Cyclohexanones; Fibrosis; In Situ Nick-End Labeling; Leukocyte Common Antigens; Leukocyte Count; NF-kappa B; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Ureter; Ureteral Obstruction

2003